MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Apathy"

  • 2016 International Congress

    Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

    C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

    Objective: Refine understanding of the processes underpinning apathy in neurodegenerative disease, by identifying 1) objective measures to assess apathy; 2) parcellating the broad construct of…
  • 2016 International Congress

    Reward insensitivity differentiates apathy from depression in Parkinson’s disease

    K. Muhammed, M. Ben Yehuda, D. Drew, S. Manohar, T. Chong, G. Tofaris, M. Bogdanovic, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

    Objective: To determine if a potential cause of apathy in Parkinson's disease (PD) might be insensitivity to rewards, establish if this differentiates apathy from depression…
  • 2016 International Congress

    Screening for neuropsychiatric symptoms in Parkinson’s disease

    M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)

    Objective: To determine the convergent validity of the screening questions included in instructions to patients for Part 1A of the International Parkinson and Movement Disorder…
  • 2016 International Congress

    Effect of STN-DBS on impulse control disorder and affective behavioral complications of Parkinson’s disease: A 1-year longitudinal study

    S.M. Omarova, N.V. Fedorova, E.V. Bril, A.A. Tomskiy, A.A. Gamaleya (Moscow, Russia)

    Objective: In this 1-year prospective study, we evaluated the effect of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) on neuropsychiatric complications of…
  • 2016 International Congress

    A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)

    F. Maier, C.J. Lewis, A.A. Kühn, H. Krug, J. Volkmann, A.D. Kirsch, L. Wojtecki, A. Schnitzler, G. Deuschl, J.K. Krauss, C. Woopen, L. Timmermann (Cologne, Germany)

    Objective: To develop a questionnaire that measures impairments related to deep brain stimulation (DBS). Background: DBS has considerable influence on motor and non-motor symptoms in…
  • 2016 International Congress

    Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

    P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

    Objective: To evaluate the prevalence, interrelation and impact on health related quality of life (HRQL) and Activities of daily Living (ADL) of motor (MS) and…
  • 2016 International Congress

    Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease

    S.J. Chung, J.J. Lee, J.H. Ham, P.H. Lee, Y.H. Sohn (Seoul, Korea)

    Objective: We performed this study to investigate whether dopamine depletion in the ventral striatum contributes to apathy in PD. Background: Apathy is a common, disabling…
  • 2016 International Congress

    Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease

    M.A. Higuchi, T. Mishima, H. Abe, T. Morishita, S. Fujioka, J. Fukae, Y. Tsuboi (Fukuoka, Japan)

    Objective: To evaluate the influence of pretreatment subclinical apathy on patient QOL following subthalamic nucleus DBS (STN-DBS) in PD patients 12 months after surgery. Background:…
  • 2016 International Congress

    Relationship between the MDS-UPDRS and quality of life in Parkinson’s disease: A large international multicenter study of 3206 patients (the QUALPD study)

    M. Škorvánek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A.E. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gerschanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

    Objective: To evaluate the relationship between the International Parkinson and Movement Disorder Society – Unified Parkinson's disease Rating Scale (MDS-UPDRS) and Quality of Life (QoL)…
  • 2016 International Congress

    Relationships of cognitive functions and psychiatric symptoms with motor phenotypes in patients with untreated early-stage Parkinson’s disease

    H. Terashi, Y. Ishimura, T. Taguchi, H. Mitoma, H. Aizawa (Tokyo, Japan)

    Objective: It has been shown that the clinical types of Parkinson's disease (PD) based on motor symptoms include motor phenotypes of postural instability and gait…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley